BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23332244)

  • 1. Predictive value of angiographic scores for the integrated management of the ischemic diabetic foot.
    Bargellini I; Piaggesi A; Cicorelli A; Rizzo L; Cervelli R; Iacopi E; Lunardi A; Cioni R
    J Vasc Surg; 2013 May; 57(5):1204-12. PubMed ID: 23332244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year technical and clinical outcomes in TransAtlantic Inter-Society Consensus II infrainguinal C/D lesions using duplex ultrasound arterial mapping as the sole imaging modality for critical lower limb ischemia.
    Sultan S; Tawfick W; Hynes N
    J Vasc Surg; 2013 Apr; 57(4):1038-45. PubMed ID: 23321343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia.
    Utsunomiya M; Nakamura M; Nakanishi M; Takagi T; Hara H; Onishi K; Yamada T; Sugi K
    J Vasc Surg; 2012 Jan; 55(1):113-21. PubMed ID: 21943874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
    Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
    J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
    Sultan S; Hynes N
    J Cardiovasc Surg (Torino); 2014 Dec; 55(6):813-25. PubMed ID: 25216216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.
    Darling JD; McCallum JC; Soden PA; Meng Y; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2016 Sep; 64(3):616-22. PubMed ID: 27380993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
    Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
    J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme endovascular revascularization for limb salvage in critical limb ischemia.
    Mandolfino T; Canciglia A; Lamberto S; Calogero S; D'Alfonso M; Bottari A
    Int Angiol; 2012 Apr; 31(2):163-8. PubMed ID: 22466982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.
    Lichtenberg M; Stahlhoff W; Boese D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):433-9. PubMed ID: 24013531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization by angioplasty of type D femoropopliteal and long infrapopliteal lesion in diabetic patients with critical limb ischemia: are TASC II recommendations suitable? A population-based cohort study.
    Faglia E; Clerici G; Airoldi F; Tavano D; Caminiti M; Curci V; Mantero M; Morabito A; Edmonds M
    Int J Low Extrem Wounds; 2012 Dec; 11(4):277-85. PubMed ID: 23089965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):32S-42S. PubMed ID: 20435260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of one-year prognosis of patients classified as chronic critical lower limb ischaemia according to TASC II or European consensus definition in the COPART cohort.
    Vircoulon M; Boulon C; Desormais I; Lacroix P; Aboyans V; Bura-Riviere A; Cambou JP; Becker F; Constans J
    Vasa; 2015 May; 44(3):220-8. PubMed ID: 26098326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subintimal angioplasty for advanced lower extremity ischemia due to TASC II C and D lesions of the superficial femoral artery.
    Sidhu R; Pigott J; Pigott M; Comerota A
    Vasc Endovascular Surg; 2010 Nov; 44(8):633-7. PubMed ID: 20675324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.
    Darling JD; McCallum JC; Soden PA; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2017 Mar; 65(3):695-704. PubMed ID: 28073665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoluminal intervention for limb salvage after failed lower extremity bypass graft.
    Simosa HF; Malek JY; Schermerhorn ML; Giles KA; Pomposelli FB; Hamdan AD
    J Vasc Surg; 2009 Jun; 49(6):1426-30. PubMed ID: 19497501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.